STAAR Surgical Company
STAA · NASDAQ
11/5/2025 | 9/26/2025 | 6/27/2025 | 3/28/2025 | |
|---|---|---|---|---|
| Market Cap | $1 | – | $1 | $1 |
| - Cash | $0 | – | $0 | $0 |
| + Debt | $0 | – | $0 | $0 |
| Enterprise Value | $1 | – | $1 | $1 |
| Revenue | – | $0 | $0 | $0 |
| % Growth | – | 113.7% | 4.1% | – |
| Gross Profit | – | $0 | $0 | $0 |
| % Margin | – | 82.2% | 74% | 65.8% |
| EBITDA | – | $0 | -$0 | -$0 |
| % Margin | – | 27.9% | -51.3% | -76.1% |
| Net Income | – | $0 | -$0 | -$0 |
| % Margin | – | 9.4% | -37.9% | -127.3% |
| EPS Diluted | – | 0.18 | -0.34 | -1.1 |
| % Growth | – | 152.9% | 69.1% | – |
| Operating Cash Flow | $0 | – | -$0 | -$0 |
| Capital Expenditures | -$0 | – | -$0 | -$0 |
| Free Cash Flow | $0 | – | -$0 | -$0 |